
Seelos Therapeutics Inc
NASDAQ:SEEL

Intrinsic Value
The intrinsic value of one
SEEL
stock under the Base Case scenario is
75.02
USD.
Compared to the current market price of 0.39 USD,
Seelos Therapeutics Inc
is
Undervalued by 99%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Fundamental Analysis


Revenue & Expenses Breakdown
Seelos Therapeutics Inc
Balance Sheet Decomposition
Seelos Therapeutics Inc
Current Assets | 2.3m |
Cash & Short-Term Investments | 294k |
Receivables | 188k |
Other Current Assets | 1.9m |
Non-Current Assets | 47k |
PP&E | 47k |
Free Cash Flow Analysis
Seelos Therapeutics Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Seelos Therapeutics Inc
Revenue
|
2m
USD
|
Operating Expenses
|
-31.8m
USD
|
Operating Income
|
-29.8m
USD
|
Other Expenses
|
33.9m
USD
|
Net Income
|
4.1m
USD
|
SEEL Profitability Score
Profitability Due Diligence
Seelos Therapeutics Inc's profitability score is 32/100. The higher the profitability score, the more profitable the company is.

Score
Seelos Therapeutics Inc's profitability score is 32/100. The higher the profitability score, the more profitable the company is.
SEEL Solvency Score
Solvency Due Diligence
Seelos Therapeutics Inc's solvency score is 21/100. The higher the solvency score, the more solvent the company is.

Score
Seelos Therapeutics Inc's solvency score is 21/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SEEL Price Targets Summary
Seelos Therapeutics Inc
Dividends
Current shareholder yield for SEEL is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?